These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Exploring the Use of State Medical Cannabis Legislation as a Proxy for Medical Cannabis Use Among Patients Receiving Chemotherapy. Gressler LE; Baltz AP; Costantino RC; Slejko JF; Onukwugha E Curr Treat Options Oncol; 2020 Nov; 22(1):1. PubMed ID: 33215230 [TBL] [Abstract][Full Text] [Related]
6. Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain. Makary P; Parmar JR; Mims N; Khanfar NM; Freeman RA J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):216-225. PubMed ID: 31070496 [TBL] [Abstract][Full Text] [Related]
7. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. Krcevski-Skvarc N; Wells C; Häuser W Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767 [TBL] [Abstract][Full Text] [Related]
8. Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. Turgeman I; Bar-Sela G Expert Opin Investig Drugs; 2019 Mar; 28(3):285-296. PubMed ID: 30572744 [TBL] [Abstract][Full Text] [Related]
9. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. Gotfried J; Naftali T; Schey R Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910 [TBL] [Abstract][Full Text] [Related]
10. An overview of ondansetron for chemotherapy-induced nausea and emesis. San Angel F J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782 [TBL] [Abstract][Full Text] [Related]
11. Evidence to support use of palonosetron over generic serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting. Yeh YC; Blouin GC; Reddy P Am J Health Syst Pharm; 2014 Mar; 71(6):500-6. PubMed ID: 24589541 [No Abstract] [Full Text] [Related]
12. Netupitant/palonosetron (Akynzeo) for chemotherapy-induced nausea and vomiting. Med Lett Drugs Ther; 2015 Apr; 57(1467):61-3. PubMed ID: 25897549 [No Abstract] [Full Text] [Related]
14. Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting. Mortimer TL; Mabin T; Engelbrecht AM Future Oncol; 2019 Mar; 15(9):1035-1049. PubMed ID: 30720344 [TBL] [Abstract][Full Text] [Related]
15. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting. Cope D Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282 [No Abstract] [Full Text] [Related]
16. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist. Egan AP; Taggart JR; Bender CM Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124 [TBL] [Abstract][Full Text] [Related]
17. Medicinal use of marijuana. Mathre ML Am J Nurs; 1997 Nov; 97(11):23. PubMed ID: 9372704 [No Abstract] [Full Text] [Related]
18. The management of chemotherapy-induced nausea and vomiting. Gralla RJ; Tyson LB; Kris MG; Clark RA Med Clin North Am; 1987 Mar; 71(2):289-301. PubMed ID: 3546981 [TBL] [Abstract][Full Text] [Related]
19. [The magic plant as an antiemetic. Cannabinoids for treatment of nausea and vomiting]. Kreutz S Pharm Unserer Zeit; 2007; 36(5):389-92. PubMed ID: 17722146 [No Abstract] [Full Text] [Related]